Water Soluble Ball Delivers Accurate Quantitative Microbiological Control

Dubbed BioBall, the standard ball products are derived from strains sourced from internationally recognized culture collections.

bioMérieux, (Marcy l'Etoile, France), a leader in the field of in vitro diagnostics (IVD) and in microbiological control for the biopharma and food industries, developed BioBall to provide pharmaceutic microbiology laboratories with their own isolates in a convenient, easy-to-use format.

Many pharmaceutic companies implement standard operating procedures that incorporate several representative strains from among their own bacterial and fungal isolates (from environmental monitoring, sterility, or bioburden testing). Maintaining these strains in-house is time-consuming and costly compared with the quality control (QC) strains such as BioBall that are available for routine use.

BTF (Sydney, Australia), a bioMérieux company, developed the BioBall Plant Isolate service in response to changing practices in culture media quality control for validation and routine testing. BioBall Plant Isolate will enable customers to implement best practices in media QC for their critical environmental monitoring and sterility testing.

BioBall mixed kits contain the most relevant pharmacopeia strains required for quantitative microbiology. Three different products for pharmaceutic QC are available: BioBall SingleShot, BioBall MultiShot 550, and BioBall MultiShot 10E8

BioBall SingleShot mixed kit and BioBall MultiShot 550 mixed kit contain two vials of Aspergillus brasiliensis, two vials of Bacillus subtilis, one vial of Candida albicans, one vial of Escherichia coli, two vials of Pseudomonas aeruginosa, and two vials of Staphylococcus aureus.

BioBall MultiShot 10E8 contains the same mixture of bacteria without C. albicans.

Related Links:
bioMérieux
BTF